ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 5, 2020

Total Value ($000): $76,733 (100.0% shares, 0.0% debt)

Holdings (5)

— RUBIUS THERAPEUTICS INC 32.4%

Value ($000) $24,874 Shares 2,618,351 Est. Cost $16.08 Unrealized —

— SYROS PHARMACEUTICALS INC 29.8%

Value ($000) $22,898 Shares 3,313,817 Est. Cost $10.38 Unrealized —

— ADESTO TECHNOLOGIES CORP. 22.7%

Value ($000) $17,438 Shares 2,051,511 Est. Cost $8.50 Unrealized —

— CHIASMA INC 7.7%

Value ($000) $5,936 Shares 1,196,776 Est. Cost $3.11 Unrealized —

KURA KURA ONCOLOGY INC 7.3%

Value ($000) $5,587 Shares 406,307 Est. Cost $13.25 Unrealized +11.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RUBIUS THERAPEUTICS INC	2,618,351	$24,874	32.4%	$16.08	—	COM	78116T103
—	SYROS PHARMACEUTICALS INC	3,313,817	$22,898	29.8%	$10.38	—	COM	87184Q107
—	ADESTO TECHNOLOGIES CORP.	2,051,511	$17,438	22.7%	$8.50	—	COM	00687D101
—	CHIASMA INC	1,196,776	$5,936	7.7%	$3.11	—	COM	16706W102
KURA	KURA ONCOLOGY INC	406,307	$5,587	7.3%	$13.25	+11.8%	COM	50127T109